Author Archives: Hank

Drug Firms Must Swallow Bitter Pill It’s “crunch time” for the pharmaceutical sector and drug makers are worried sick. Representatives from the sector descended upon London this week to discuss the industry’s ailments. All were stunned by the bleak outlook. … Continue reading →

Pharmacists ‘should be trained for industry changes’ Those employed in pharmacy jobs should be trained to deal with the changes in the industry, one expert maintains. Rob Darracott, chief executive of Pharmacy Voice, said that with the immigration caps coming … Continue reading →

FDA issues warning letter to makers of ‘Viagra coffee’ Magic Power Coffee has come under government scrutiny for claiming its product, which is only sold online, is a “100% natural” dietary supplement that can enhance sexual performance. However, a Food … Continue reading →

Plan to curb prescription fraud questioned Members of the Arizona State Board of Pharmacy are questioning the city of Peoria’s proposals to curb fraud in painkiller prescriptions. City officials have proposed measures that include requiring pharmacists to take fingerprints before … Continue reading →

College of Pharmacy Named Top Partner by CVS Caremark CVS Caremark, the largest pharmacy health care provider in the U.S., named WesternU’s College of Pharmacy as its 2010 Partner of the Year. CVS officials surprised College of Pharmacy administration and … Continue reading →

Watson Confirms Pataday™ Patent Challenge Watson Pharmaceuticals, Inc. (NYSE: WPI) today confirmed that its subsidiary, Watson Laboratories, Inc., filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Olopatadine Hydrochloride Ophthalmic … Continue reading →

Cancer Drug Developers Considering ImmunoGen’s Tap Technology Something to think about: The fact that using ImmunoGen’s (IMGN) TAP technology makes targeted cancer drugs beat their own efficacy. This reality seems to be increasingly considered by cancer drug developers. Using ImmunoGen’s … Continue reading →

New Hepatitis C Drug Wins FDA Approval Vertex Pharmaceutical’s hepatitis C drug, telprevir, received Food and Drug Administration (FDA) approval Monday not long after the agency cleared a competing medicine by Merck. Telprevir, which will be marketed under the brand … Continue reading →

Labor Will Be Less of a Drag on Drugstores Pharmacist-wage inflation has been a meaningful earnings headwind for drugstores over the past decade, but structural changes in the labor market should provide significant relief going forward. Our proprietary analysis suggests … Continue reading →

Obama Suggests US Should Be Able To Negotiate Drug Prices WASHINGTON -(Dow Jones)- President Barack Obama on Thursday said prescription drug costs should be lower, and suggested giving the government power to directly negotiate drug prices and allowing medicines to … Continue reading →